This image shows the prevalence of major depressive disorder across the world. The age standardized prevalence rate of MDD in 2021 varied across the globe – prevalence was highest in Greenland at 6.6%, and lowest in Brunei Darussalam at 1.2%
MDD=major depressive disorder
Related content
Treatment-resistant depression (TRD) represents a significant clinical challenge, affecting approximately 30% of individuals with major depressive disorder (MDD) who fail to respond to at least two adequate antidepressant trials.
Sequential treatment optimization scheme for major depressive disorder generated according to international evidence.
Key steps for managing factors that may confound antidepressant treatment response, including dose, side effects, comorbidities, stressors, adherence, pharmacogenomics, interactions, and treatment algorithms.